Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trypsinogen expression in colorectal cancers.

K Oyama1, T Ohta, G I Nishimura

  • 1Department of Surgery II, School of medicine, Kanazawa University, Kanazawa 920-8640, Japan.

International Journal of Molecular Medicine
|October 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection.

Gastroenterology research and practice·2012
Same author

Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA.

International journal of cancer·2001
Same author

Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer.

Hepato-gastroenterology·2001
Same author

Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway.

International journal of oncology·2001
Same author

Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.

International journal of oncology·2000
Same author

[An effective case of hepatic arterial infusion chemotherapy based on biochemical modulation for hepatic recurrence of non-functioning islet cell carcinoma of the pancreas].

Gan to kagaku ryoho. Cancer & chemotherapy·2000

Trypsinogen expression was detected in human colorectal cancers, suggesting its potential role in cancer invasion and metastasis. Further research is needed to understand its precise involvement in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Colorectal cancer (CRC) is a significant global health concern.
  • Understanding molecular markers involved in CRC progression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression of trypsinogen in human colorectal cancer.
  • To explore the potential association between trypsinogen and clinicopathological features of CRC.

Main Methods:

  • Reverse transcriptase-polymerase chain reaction (RT-PCR) for mRNA expression analysis.
  • Gelatin zymography to assess enzymatic activity in cancer cell conditioned media.
  • Immunohistochemistry (IHC) to evaluate trypsinogen protein levels in surgical specimens.

Related Experiment Videos

Main Results:

  • Trypsinogen-1 mRNA was detected in 50% of CRC cell lines.
  • Gelatinolytic activity at acidic pH was observed in cancer cell conditioned media.
  • Trypsinogen protein was expressed in 44.2% of colorectal cancer surgical specimens.
  • No significant correlation was found between trypsinogen expression and clinicopathological findings.

Conclusions:

  • Trypsinogen is expressed in human colorectal cancer tissues and cell lines.
  • The findings suggest a potential role for trypsinogen in cancer invasion and metastasis.
  • Further investigation is warranted to elucidate the specific mechanisms of trypsinogen in CRC progression.